MORE►
2024 DEC Network State of Entrepreneurship awards
Kristy Alballero, co-founder and COO of IOOGO. [Photo: IOOGO]
The Last Word: IOOGO’s Kristy Alballero On the ‘ALL-Women’ Award Winners at The DEC Network’s State of Entrepreneurship 2024
by Dallas Innovates | Staff Report | Mar 8, 2024
Today is International Women's Day, and many women entrepreneurs across North Texas are still basking in the glow of something that happened Thursday night: As Alballero said in her post, The DEC Network's 2024 State of Entrepreneurship event featured an all-star cast of women among its entrepreneur award winners.
Related Articles
Comerica Names Veteran Banking Exec as Chief Investment Officer
Fortis Names 2 New C‑Suite Leaders to Accelerate Embedded Payments Growth
Secretome Therapeutics Appoints New Chief Medical Officer
‘The Smurf Experience’ To Make U.S. Debut in North Texas May 7
Dallas-Based StenTech Merges With New Jersey’s BlueRing
MORE►
Trending
North Texas is a big place, with plenty to do, see, hear, and watch. We scour the internet every week to find events and activities for you. As always, things may change at any time, so be sure to check the official website or registration page for the latest details....
More than two years since generative AI exploded onto the radar of business leaders, the technology continues to mature. In 2025, AI is capable of driving real results across the enterprise....
Veteran banking executive Eric Teal has been named chief investment officer of Dallas-based Comerica Inc. He will be responsible for providing enterprise-wide leadership of investment strategy, portfolio construction, and enhancement of the Comerica Investment Management brand, Comerica said....
Plano-based payment technology provider Fortis has appointed two industry veterans to its executive leadership team: Brad Bialas as chief commercial officer and Kimling Lam as chief marketing officer.
Fortis said the appointments position Fortis for its next phase of aggressive growth across the software and ERP ecosystem....
Marshelle Smith Warren, MD, has been appointed chief medical officer of Dallas-based Secretome Therapeutics, a clinical-stage biotechnology company that is pioneering therapies derived from neonatal cardiac progenitor cells (nCPCs).
The company said Warren is a highly experienced pharmaceutical executive with more than two decades of leadership in clinical development, translational medicine, and regulatory strategy across multiple therapeutic areas, including cell therapy, immunology, cardiovascular, and rare diseases....
Trending
North Texas is a big place, with plenty to do, see, hear, and watch. We scour the internet every week to find events and activities for you. As always, things may change at any time, so be sure to check the official website or registration page for the latest details....
More than two years since generative AI exploded onto the radar of business leaders, the technology continues to mature. In 2025, AI is capable of driving real results across the enterprise....
Veteran banking executive Eric Teal has been named chief investment officer of Dallas-based Comerica Inc. He will be responsible for providing enterprise-wide leadership of investment strategy, portfolio construction, and enhancement of the Comerica Investment Management brand, Comerica said....
Plano-based payment technology provider Fortis has appointed two industry veterans to its executive leadership team: Brad Bialas as chief commercial officer and Kimling Lam as chief marketing officer.
Fortis said the appointments position Fortis for its next phase of aggressive growth across the software and ERP ecosystem....
Marshelle Smith Warren, MD, has been appointed chief medical officer of Dallas-based Secretome Therapeutics, a clinical-stage biotechnology company that is pioneering therapies derived from neonatal cardiac progenitor cells (nCPCs).
The company said Warren is a highly experienced pharmaceutical executive with more than two decades of leadership in clinical development, translational medicine, and regulatory strategy across multiple therapeutic areas, including cell therapy, immunology, cardiovascular, and rare diseases....
